A pooled analysis of nivolumab for the treatment of advanced non-small-cell lung cancer and the role of PD-L1 as a predictive biomarker
Aguiar, Pedro N, Santoro, Ilka Lopes, Tadokoro, Hakaru, de Lima Lopes, Gilberto, Filardi, Bruno Andraus, Oliveira, Pedro, Castelo-Branco, Pedro, Mountzios, Giannis, de Mello, Ramon AndradeТом:
8
Мова:
english
Журнал:
Immunotherapy
DOI:
10.2217/imt-2016-0032
Date:
September, 2016
Файл:
PDF, 2.21 MB
english, 2016
File converter
Більше результатів пошуку
More benefits 
